PeriNess Ltd. is a biopharmaceutical company that is committed to, and engaged in the development of a new drug for enhancement of male fertility. The company has discovered a unique enzyme, DNase I, that can significantly enhance the fertility of sub-fertile males
Male subfertility is any health issue in a man that lowers the chances of his female partner getting pregnant.
A man’s fertility generally depends on the quantity and quality of his sperm.
One couple out of five experience difficulty in conceiving. In about half of all sub-fertile couples, male sub-fertility is observed, and in almost 40% of such couples the sub-fertility is solely due to male factors.
The vast majority of male sub-fertility is idiopathic,
preventing the logical development of an effective treatment.